Downregulation of Sfrp5 promotes beta cell proliferation during obesity in the rat-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Downregulation of Sfrp5 promotes beta cell proliferation during obesity in the rat

Published:2013-09-05 Issue:11 Volume:56 Page:2446-2455
ISSN:0012-186X
Container-title:Diabetologia
language:en
Short-container-title:Diabetologia

Author:

Rebuffat Sandra A.,Oliveira Joana M.,Altirriba Jordi,Palau Nuria,Garcia Ainhoa,Esteban Yaiza,Nadal Belen,Gomis Ramon

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00125-013-3030-x.pdf

Reference41 articles.

1. Stumvoll M, Goldstein BJ, van Haeften TW (2005) Type 2 diabetes: principles of pathogenesis and therapy. Lancet 365:1333–1346

2. Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC (1994) Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 17:961–969

3. Kershaw EE, Flier JS (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89:2548–2556

4. Bonner-Weir S (2000) Life and death of the pancreatic beta cells. Trends Endocrinol Metab 11:375–378

5. Bonner-Weir S (2000) Islet growth and development in the adult. J Mol Endocrinol 24:297–302

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic significance of serum secreted frizzled-related protein 5 in patients with acute aortic dissection;Heliyon;2024-08

2. Frizzled receptors and SFRP5 in lipid metabolism: Current findings and potential applications;Progress in Molecular Biology and Translational Science;2023

3. Dipeptidylpeptidase (DPP)-4 inhibitor therapy increases circulating levels of anti-inflammatory soluble frizzle receptor protein (sFRP)-5 which is decreased in severe COVID-19 disease;Scientific Reports;2022-09-02

4. Pancreatic Islets as a Target of Adipokines;Comprehensive Physiology;2022-08-11

5. New Discovered Adipokines Associated with the Pathogenesis of Obesity and Type 2 Diabetes;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2022-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3